Dexmedetomidine Hydrochloride Injection shortage
Dexmedetomidine Hydrochloride Injection is currently listed in shortage by the FDA. The FDA lists 59 affected products. The reported reason: Other; Delay in shipping of the drug; Discontinuation of the manufacture of the drug. This page was last refreshed from FDA data on Sep 22, 2026.
Some makers of dexmedetomidine hydrochloride injection have reported a shortage lasting over a year. The same medicine — including Precedex — is still listed as available from other manufacturers not reporting a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Dexmedetomidine Hydrochloride Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Sep 17, 2026Currently in shortage59 of 59 products affected.
-
Sep 16, 2026FDA refreshed this shortage record4 products updated.
-
Sep 15, 2026FDA refreshed this shortage record9 products updated.
-
Sep 11, 2026FDA refreshed this shortage record2 products updated.
-
Sep 8, 2026FDA refreshed this shortage record13 products updated.
-
Aug 27, 2026FDA refreshed this shortage record1 product updated.
-
Aug 24, 2026FDA refreshed this shortage record2 products updated.
-
Aug 18, 2026FDA refreshed this shortage record1 product updated.
-
Aug 17, 2026FDA refreshed this shortage record5 products updated.
-
Aug 13, 2026FDA refreshed this shortage record1 product updated.
-
Jul 22, 2026FDA refreshed this shortage record3 products updated.
-
Jun 17, 2026FDA refreshed this shortage record4 products updated.
-
Jun 5, 2026FDA refreshed this shortage record2 products updated.
-
Jun 5, 2026More presentations reported2 more products added to the shortage.
-
Apr 21, 2026FDA refreshed this shortage record1 product updated.
-
Apr 21, 2026More presentations reported1 more product added to the shortage.
-
Apr 10, 2021More presentations reported1 more product added to the shortage.
-
Apr 10, 2020First reported to the FDA55 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Accord Healthcare Inc. 📞 866-941-7875, option 2 3 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | — | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93) | — | Unavailable | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
| To Be Discontinued | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93) | — | — | Discontinuation of the manufacture of the drug | — |
Manufacturer: Amneal Pharmaceuticals 📞 866-525-7270 4 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8) | — | Available | Inventory available 4 to 5 month as per current demand. Next supply: week of 06/29/2026 | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7) | — | Available | — | — |
Manufacturer: Azurity Pharmaceuticals, Inc 📞 877-495-6856 4 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08) | — | Available | Distributed by Wilshire Pharmaceuticals, Inc. | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10) | — | Available | Distributed by Civica | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10) | — | Available | Distributed by Wilshire Pharmaceuticals, Inc. | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08) | — | Available | Distributed by Civica | — |
Manufacturer: Baxter Healthcare 📞 888-229-0001 4 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24) | — | Unavailable | Estimated recovery: September 2026 | Other |
Manufacturer: Eugia US LLC 📞 888-238-7880 3 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10) | — | Available | Check wholesalers for inventory | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02) | — | Available | Check wholesalers for inventory | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10) | — | Available | Check wholesalers for inventory | — |
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 4 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00) | — | Unavailable | Expected recovery: TBD | Delay in shipping of the drug |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20) | — | Unavailable | Expected recovery: TBD | Other |
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02) | — | Unavailable | Estimated recovery: TBD | Demand increase for the drug |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50) | — | Unavailable | Estimated recovery: TBD | Delay in shipping of the drug |
Manufacturer: Gland Pharma Limited 📞 Distributed by DRL 3 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58) | — | Available | Distributed by DRL | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58) | — | Available | Distributed by DRL | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42) | — | Available | Marketed by Piramal Critical Care Inc.: 800-414-1901 | — |
Manufacturer: HQ Specialty Pharma 📞 WG Critical Care 888-493-0861 4 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) | — | Available | Marketed by WG Critical Care | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) | — | Available | Marketed by WG Critical Care | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) | — | Available | Marketed by WG Critical Care | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) | — | Available | Marketed by WG Critical Care | — |
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 800-631-2174 1 NDC click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25) | — | Unavailable | Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe. | Demand increase for the drug |
Manufacturer: Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) 📞 See Related Information section below for customer service information 1 NDC click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02) | — | Available | Distributed by Avenacy; Contact information: 877-283-6229 | — |
Manufacturer: Jiangsu Hengrui Pharmaceuticals Co., Ltd. 📞 See Related Information section below for customer service information 3 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95) | — | Available | Marketed by Sandoz Inc.; Customer service: 800-525-8747 | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95) | — | Available | Marketed by Sandoz Inc.; Customer service: 800-525-8747 | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95) | — | Available | Marketed by Sandoz Inc.; Customer service: 800-525-8747 | — |
Manufacturer: Meitheal Pharmaceuticals, Inc. 📞 844-824-8426 1 NDC click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03) | — | Available | — | — |
Manufacturer: Mylan Institutional, a Viatris Company 📞 800-796-9526 3 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10) | — | Available | — | — |
Manufacturer: Par Health, USA LLC 📞 800-828-9393 3 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20) | — | Unavailable | Estimated recovery: TBD; Please check wholesalers for inventory | Other |
| Current | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10) | — | Unavailable | Estimated recovery: TBD; Please check wholesalers for inventory | Other |
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25) | — | Available | Please check wholesalers for inventory | — |
Manufacturer: Pfizer Inc. 📞 844-646-4398 14 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01) | — | Available | — | — |
| Current | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20) | — | Available | — | — |
| Current | Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12) | — | Available | — | — |
| Current | Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24) | — | Available | — | — |
| Current | Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24) | — | Available | — | — |
| Current | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20) | — | Available | — | — |
| Current | Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01) | — | Available | — | — |
| Current | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20) | — | Available | — | — |
| Current | Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02) | — | Available | — | — |
| Current | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02) | — | Available | — | — |
| Current | Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50) | — | Available | — | — |
| Current | Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10) | — | Available | — | — |
| Current | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10) | — | Available | — | — |
| Current | Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10) | — | Available | — | — |
Manufacturer: Slayback Pharma 📞 800-461-7449 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05) | — | — | Discontinuation of the manufacture of the drug | — |
Manufacturer: Somerset Therapeutics, LLC 📞 732-554-1037 2 NDCS click to expand
| Status | NDC / product | Strength / size | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04) | — | Available | — | — |
| Current | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Dexmedetomidine Hydrochloride Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Dexmedetomidine Hydrochloride Injection? options further down this page.
Why is Dexmedetomidine Hydrochloride Injection in shortage?
Dexmedetomidine is on the FDA shortage list because several manufacturers are running into different problems at the same time. For Fresenius Kabi, a few of their 4 mcg/mL vial sizes are being held up due to shipping delays, and their 100 mcg/mL vial is in short supply because more people need it than usual — no firm recovery date has been given for any of these. Baxter's 200 mcg/50 mL bag (NDC 0338-9555-24) is also currently unavailable, with an estimated return to supply around September 2026. On top of that, the notes mention that at least one 100 mcg/mL product marketed by WG Critical Care is temporarily on backorder, with additional supply expected in the September 2026 timeframe, and at least one 4 mcg/mL product line is being permanently discontinued by its maker.
The good news is that several strengths and package sizes from multiple manufacturers — including Pfizer's full Precedex line, Baxter's other bag sizes, Sandoz, Somerset Therapeutics, and Gland Pharma — are currently listed as available. So while some specific products are affected, not every version of this medication is in short supply right now.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Dexmedetomidine Hydrochloride Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Dexmedetomidine Hydrochloride Injection?
Dexmedetomidine hydrochloride injection is currently on the FDA drug-shortage list. This is a medicine used in hospital and clinical settings, and I want to walk you through what the reported data shows so you know where things stand.
Every strength on this record still has an available source right now — 20 of 20 strengths are covered, and 13 of the 17 manufacturers on this record are still reporting supply. That includes strengths such as the 80 mcg/20 mL, 100 mcg/1 mL, 200 mcg/50 mL, 400 mcg/100 mL, and the 4 mcg/mL concentrations. A few specific products from certain makers are marked unavailable — for example, some 4 mcg/1 mL and 100 mcg/1 mL items from Fresenius Kabi, and Baxter's 200 ug/50 mL (estimated recovery September 2026). One maker, Accord, has discontinued its 100 ug/1 mL product. Reported reasons across the record include shipping delays, a demand increase, and some discontinuations.
Because this medicine is given by your care team, here is what to keep in mind:
- Do not stop, skip, or change how you receive this medicine on your own.
- Since your strength likely still has supply, your pharmacy or clinic can check wholesalers and other manufacturers to order it.
- The same medicine is made by several other companies (for example Hikma, Sagent, Sun, Amneal, and others), so your pharmacy may be able to source one — though it may not be in local stock.
- If a specific product is discontinued or cannot be found, ask your prescriber or pharmacist about options.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general national information and may not match local stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Dexmedetomidine Hydrochloride Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Dexmedetomidine Hydrochloride Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection, Solution · Intravenous | Hikma Pharmaceuticals USA Inc. | 00143-9198-10 |
| Precedex | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection, Solution · Intravenous | Hospira, Inc. | 00409-1596-01 |
| Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection, Solution · Intravenous | Sagent Pharmaceuticals | 25021-0615-50 |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection · Intravenous | Sagent Pharmaceuticals | 25021-0617-82 |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 200 ug/50mL | Injection · Intravenous | Baxter Healthcare Company | 43066-0561-24 |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 400 ug/100mL | Injection · Intravenous | Baxter Healthcare Company | 43066-0565-12 |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 100 ug/mL | Injection, Solution · Intravenous | Sun Pharmaceuticals Industries, Inc. | 57664-0596-50 |
| Dexmedetomidine | DEXMEDETOMIDINE HYDROCHLORIDE 200 ug/2mL | Injection, Solution · Intravenous | Piramal Critical Care Inc | 66794-0233-42 |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection · Intravenous | Piramal Critical Care Inc | 66794-0234-44 |
| Dexmedetomidine Hydrochloride In Sodium Chloride | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection, Solution · Intravenous | Precision Dose, Inc. | 68094-0147-20 |
| Dexmedetomidine Hydrochloride | DEXMEDETOMIDINE HYDROCHLORIDE 4 ug/mL | Injection · Intravenous | Amneal Pharmaceuticals LLC | 70121-1711-02 |
Alternative dosage forms of Dexmedetomidine Hydrochloride
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths / sizes, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Dexmedetomidine HCl 100 ug/mL | Hikma | 25 vials | — | AP | FDA listed |
| Precedex 100 ug/mL | Henry | 1 vial | — | AP | FDA listed |
| Precedex 100 ug/mL | Hospira, | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Accord | 25 vials | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Baxter | 5 vials | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Par | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Eugia | 25 vials | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Sun | 25 vials | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Fresenius | 25 vials | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Fresenius | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 200 ug/2mL | Piramal | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 200 ug/2mL | Piramal | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Mylan | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Gland | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Meitheal | 25 vials | — | AP | FDA listed |
| Dexmedetomidine hydrochloride 100 ug/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 100 ug/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexmedetomidine HCl 100 ug/mL | Medical | 1 vial | — | AP | FDA listed |
| Dexmedetomidine 200 ug/2mL | Medical | 1 vial | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Avenacy | 25 vials | — | AP | FDA listed |
| Dexmedetomidine 200 ug/2mL | ProPharma | 2 ml | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | ProPharma | 2 ml | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | WG | 4 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | WG | 4 vials | — | AP | FDA listed |
| Dexmedetomidine 100 ug/mL | Accord | 25 vials | — | AP | Discontinued |
| Dexmedetomidine Hydrochloride 4 ug/mL | Hikma | 10 pouches | — | AP | FDA listed |
| Dexmedetomidine Hydrochloride 200 ug/50mL | Baxter | 50 ml | — | AP | FDA listed |
| Precedex 4 ug/mL | Hospira, | 20 bottles | — | AP | FDA listed |
| Precedex 4 ug/mL | Hospira, | 10 bottles | — | AP | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Dexmedetomidine Hydrochloride Injection — that fall in the same broad treatment class (sedative-hypnotics,non-barbiturate) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other anesthesia shortages
Dexmedetomidine Hydrochloride Injection shortage FAQs
Is Dexmedetomidine Hydrochloride Injection in shortage?
Why is Dexmedetomidine Hydrochloride Injection in shortage?
Which products are affected?
When will Dexmedetomidine Hydrochloride Injection be available again?
Can I still get Dexmedetomidine Hydrochloride somewhere?
What should I do if I take Dexmedetomidine Hydrochloride Injection?
Still have a question about the Dexmedetomidine Hydrochloride Injection shortage?
Ask a pharmacist about this shortage →View Dexmedetomidine Hydrochloride Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.